NovaBay Pharmaceuticals, Inc. (NBY) stock is down -82.81% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NBY stock a score of 29 out of a possible 100.
That rank is influenced by a long-term technical score of 0. NBY's rank also includes a short-term technical score of 21.
Is NovaBay Pharmaceuticals, Inc. (NBY) Stock Worth a Buy Friday?
NBY has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NBY!